Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Leila Charef"'
Autor:
Mohamed Amine Bekadja, Belkacem Mansour, Hafida Ouldjeriouat, Laurent Garderet, Brahim Benzineb, Samira Bouchama, Leila Charef, Badra Entasoltan, Nabil Yafour, Sofiane Belaidi
Publikováno v:
Asian Pacific Journal of Cancer Biology, Vol 7, Iss 1, Pp 15-20 (2022)
Background: The aim of this retrospective study was to analyze early relapse in multiple myeloma (MM) in real life and to evaluate its impact on overall survival (OS) and progression-free survival (PFS). Methods: Two groups of patients were identifie
Externí odkaz:
https://doaj.org/article/926eac5ad40f46a0996d5505f27eb27f
Autor:
Mohammed Amine BEKADJA, Brahim BENZINEB, Mansour BELKACEM, Hafida OUDJERIOUAT, Badra ENTASOLTAN, Soufi OSMANI, Kamila AMANI, Samira BOUCHAMA, Leila CHAREF, Mohamed BRAHIMI, Abdessamad ARABI, Rachir Amar BOUHASS, Nabil YAFOUR
Publikováno v:
Journal de la Faculté de Médecine d'Oran, Vol 6, Iss 1 (2022)
Introduction-The objectives of our work are to measure the incidence of thrombosis and identify predictive factors during the procedure of autologous hematopoietic stem cells, during real life, in the University Hospital of Oran (Algeria). Methods-Th
Externí odkaz:
https://doaj.org/article/897100b6246e48f78c8d74db1c6eef1b
Autor:
Sofiane Belaidi, Nabil Yafour, Badra Entasoltan, Leila Charef, Samira Bouchama, Brahim Benzineb, Laurent Garderet, Hafida Ouldjeriouat, Belkacem Mansour, Mohamed Amine Bekadja
Publikováno v:
Asian Pacific Journal of Cancer Biology. 7:15-20
Background: The aim of this retrospective study was to analyze early relapse in multiple myeloma (MM) in real life and to evaluate its impact on overall survival (OS) and progression-free survival (PFS). Methods: Two groups of patients were identifie
Autor:
Mohamed Amine Bekadja, Brahim Benzineb, Hafida Ouldjeriouat, Badra ENTASOLTAN, Kamila AMANI, Samira BOUCHAMA, Leila ChAREF, Mohamed BRAHIMI, Abdessamed ARABI, Rachid Amar BOUHASS, Nabil YAFOUR
Publikováno v:
Journal de la faculté de médecine d Oran. 6
Résumé Introduction Les objectifs de notre travail sont de mesurer l’incidence de la thrombose et identifier les facteurs prédictifs au cours de la procédure d’autogreffe des cellules souches hématopoïétiques, durant la vraie vie, dans l
Autor:
Mohamed Amine Bekadja, Badra Entasoltan, Hafida Ouldjeriouat, Soufi Osmani, Mohamed Brahimi, Samira Bouchama, Leila Charef, Rachid Amar Bouhass, Abdessamed Arabi, Nabil Yafour
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 22:S148
Autor:
N. Hakiki, Kamila Amani, H. Ouldjeriouat, Mohamed Brahimi, Leila Charef, F. Bouamama, B. Mansour, Mohamed Amine Bekadja, Soufi Osmani, Abdessamed Arabi, R. Bouhass, Nabil Yafour, Badra Entasoltan, Samira Bouchama
Publikováno v:
Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis. 60(3)
Mobilization failure in patients is a major therapeutic concern which makes subsequent ASCT impossible. A new growth factor called Plerixafor (Mozobil®) developed by the pharmaceutical industry (Sanofi-aventis, France), is a chemoreceptor antagonist
Autor:
R. Bouhass, Badra Entasoltan, Leila Charef, Mohamed Amine Mazari, Mohamed Amine Bekadja, Amina Krim, Mohamed Brahimi, Kamila Amani, Samira Bouchama, Faiza Serradj, Abdessamed Arabi, Soufi Osmani, Souad Talhi, Nabil Yafour
Publikováno v:
Bone Marrow Transplantation. 53:1596-1598
Autor:
Sihem Mehded, Mohamed Amine Bekadja, Mohamed Brahimi, Abdessamed Arabi, Nabil Yafour, Mohamed Chekkal, Samira Bouchama, Leila Charef
Publikováno v:
Journal of Blood Disorders & Transfusion.
Factor XI deficiencies are very rare and the first case was registered among Ashkenazy Jews with two types of characteristic gene mutation. Today 152 mutations have been identified even among non-Jewish population. The present study reports the defic
Autor:
Leila CHaref
Publikováno v:
مجلة المؤشر للدراسات الاقتصادية. :173
Autor:
Kamila Amani, Hafida Ouldjeriouat, R. Bouhass, Amina Krim, Soufi Osmani, Souad Talhi, Samira Bouchama, Leila Charef, Nabil Yafour, Mohamed Amine Mazari, Badra Entasoltan, Mohamed Brahimi, Mohamed Amine Bekadja, Abdessamed Arabi
Publikováno v:
Blood. 128:5732-5732
Introduction: Intensive chemotherapy followed by autologous stem cell transplantation (ASCT) is currently the treatment of choice in multiple myeloma (MM). Mobilization of hematopoietic stem cell blood (HSCs) can be achieved either by the combination